TrialsgrambetaRCTs are beautiful

SOLVD

1991

Studies of Left Ventricular Dysfunction — Treatment Trial

In 2,569 patients with symptomatic heart failure and EF ≤ 0.35, enalapril reduced all-cause mortality compared with placebo.

Result

All-cause mortality
Absolute difference
4.5 points
NNT
23
Effect estimate

relative risk reduction1695% CI 5-26 · P = 0.0036

Absolute difference and NNT are derived from the event rates.

Also reported: Over mean 41.4 months; HF hospitalisations also reduced.

Original publication
Subtopic
ACE inhibitor
Design
Double-blind placebo-controlled RCT
Relevance
Important: one of several pillars.
Source
SOLVD Investigators (Yusuf S, et al). N Engl J Med. 1991;325(5):293-302.doi 10.1056/NEJM199108013250501

Discussion & critique

Predates modern background therapy (beta-blockers, MRAs, devices), so absolute benefit differs today. Foundational trial establishing ACE inhibitors as cornerstone therapy for symptomatic HFrEF.

Discussed in podcasts